Modular Biopharma Production Cells for Secure Small-Batch Manufacturing

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

Conventional production systems for pharmaceuticals, particularly in personalized therapeutics, face high costs, quality variations, production rejects, and limitations in scaling up from individual and ultrasmall batch sizes, with a need for secure and manipulation-protected manufacturing.

Innovation Solution

A production system comprising multiple processing units, a clean room area, airlock devices, handling and storage devices, and workpiece carriers, equipped with computing units and sensors, to facilitate efficient and secure manufacturing of biological-pharmaceutical products, including patient boxes, tool boxes, and tool units, enabling handling and treatment of educts in a controlled environment.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Adaptability or versatility

If manual interventions are used in production systems for personalized therapeutics, then high personalization level is achieved, but costs increase and quality variations occur

Engineering Contradiction:

Improvepersonalization levelVSAvoidquality consistency

Core Design Contradiction:

Adaptability or versatilityVSReliability

Solution Approach 1:

The patent replaces manual mechanical operations with automated robotic systems. Robots perform picking, placing, and transporting of workpieces and tools, eliminating manual interventions while maintaining high personalization through programmable control. This substitution ensures consistent quality by removing human variability from the production process.

Inventive Principle:

Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The system enables self-service through autonomous robotic units that independently execute production tasks. Each robot can autonomously handle workpieces, tools, and materials without human intervention, while the centralized control system coordinates their actions to maintain quality consistency across personalized batches.

Inventive Principle:

Principle #25Self-service

2Adaptability or versatility

If manual interventions are used for individual and ultrasmall batch production, then high personalization is achieved, but production rejects increase

Engineering Contradiction:

Improvebatch size flexibilityVSAvoidproduction yield

Core Design Contradiction:

Adaptability or versatilityVSReliability

Solution Approach 1:

Automated robotic systems replace manual operations to reduce production errors and rejects. The robots perform precise, repeatable actions for handling workpieces and tools, ensuring consistent quality even in individual and ultrasmall batch productions, thereby improving overall production yield.

Inventive Principle:

Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The system incorporates sensors and control units that continuously monitor production processes. Real-time feedback allows the system to detect and correct deviations immediately, preventing defective products and reducing rejects in personalized therapeutic production.

Inventive Principle:

Principle #23Feedback

3Adaptability or versatility

If manual operations are used in pharmaceutical production, then flexibility for personalized therapy is maintained, but security and manipulation protection are compromised

Engineering Contradiction:

Improvepersonalized therapy capabilityVSAvoidmanipulation risk

Core Design Contradiction:

Adaptability or versatilityVSObject-affected harmful factors

Solution Approach 1:

The patent replaces manual operations with automated robotic systems that execute production tasks without human contact. This eliminates the risk of manual manipulation and contamination, ensuring security and integrity of pharmaceutical products while maintaining flexibility for personalized therapy through programmable control.

Inventive Principle:

Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The system introduces automated robotic units as intermediaries between human operators and pharmaceutical products. These robots handle all operations involving workpieces and materials, acting as a protective barrier that prevents direct human contact and potential contamination, thereby enhancing security without reducing personalized therapy capability.

Inventive Principle:

Principle #24Intermediary (Mediator)

4Ease of operation

If conventional production systems are used for pharmaceuticals, then manual flexibility is maintained, but scalability to large-scale production is limited

Engineering Contradiction:

Improvemanual flexibilityVSAvoidscalability

Core Design Contradiction:

Ease of operationVSProductivity

Solution Approach 1:

The production system is divided into multiple independent robotic units, each capable of performing specific tasks. This modular segmentation allows the system to scale from individual to large-scale production by simply adding or removing robotic units, while maintaining the flexibility of manual operations through programmable control of each segment.

Inventive Principle:

Principle #1Segmentation

Solution Approach 2:

The robotic units are designed with universal capabilities to perform multiple functions including picking, placing, transporting, and handling various workpieces and tools. This multi-functionality enables the system to maintain operational flexibility while scaling up production capacity, as the same robotic units can adapt to different production volumes and product types.

Inventive Principle:

Principle #6Universality (Multi-functionality)

Data Source

PatentUS20250327755A1Production system for the manufacture of a product

Publication Date: 2025.10.23 KYOOBE TECH GMBH

AI summary

A production system for manufacturing a product, in particular a biological-pharmaceutical product, which comprises multiple processing units for accommodating and/or treating an educt, and/or to a method for this purpose.